We are happy to announce that Calmino group AB and Ewopharma (Schaffhausen, Switzerland) have entered into an exclusive distribution agreement for the territories of the Czech Republic and Slovakia to launch PROIBS® for the treatment of symptoms related to IBS. This agreement includes all marketing and sales activities of PROIBS® as of April 2022.
“With PROIBS®, we are able to provide an innovative and certified medical device for the treatment of symptoms related to IBS. The product has been on the Swedish pharmacy market for more than a decade. Because it is recommended by physicians and dietitians, we can promote PROIBS® with absolute confidence. We are looking forward to offering a solution that truly improves the liveability of the affected people.”
Ewopharma
Read the press release from Ewopharma.
Read more about PROIBS® on the Slovak and Czech websites.
Video about PROIBS® .
To learn more about PROIBS®, go to https://proibs.eu/
Looking for new products to present in your market? Can you help us enter a new market? Our goal is to maintain constant growth based on expansion into new markets and an improved presence in current markets. Should you see an opportunity for our co-operation, please do not hesitate to contact us!
Grow your business by becoming our official business partner!
